✦ LIBER ✦

P02.50. Naturopathy and yoga based life style intervention for cardiovascular risk reduction in patients with cardiovascular risk factors: a pilot study

✍ Scribed by Nandakumar, B; Kadam, A; Srikanth, H; Rao, R

Book ID: 115017616
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 101 KB
Volume: 12
Category: Article
ISSN: 1472-6882
DOI: 10.1186/1472-6882-12-s1-p106

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High prevalence of cardiovascular risk f

High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study

✍ H. D. Margeirsdottir; J. R. Larsen; C. Brunborg; N. C. Øverby; K. Dahl-Jørgensen 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 162 KB

Prevalence of conventional and lupus-spe

Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case–control study

✍ Bessant, Rupa ;Duncan, Rachel ;Ambler, Gareth ;Swanton, Jo ;Isenberg, David A. ; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

## Abstract ## Objective Patients with systemic lupus erythematosus (SLE) are significantly more likely to experience a myocardial infarction or a stroke than age‐matched controls. We compared the prevalence of conventional and lupus‐specific risk factors in patients with SLE just before a cardiov

Cardiovascular morbidity and mortality i

Cardiovascular morbidity and mortality in patients with diabetes in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

✍ L.H. Lindholm; H. Ibsen; B. Dahof 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Cardiovascular morbidity and mortality i

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

✍ Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; U 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 110 KB

Cardiovascular morbidity and mortality i

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End point reduction in hypertension (LIFE) study

✍ Kristian Wachtell; Björn Hornestam; Mika Lehto; David J. Slotwiner; Eva Gerdts; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Effects of losartan on cardiovascular mo

Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy. A losartan intervention for endpoint reduction (LIFE) study

✍ S.E. Kjeldsen; B. Dahlor; R.B. Devereux 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 33 KB